(R)-3-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

(R)-3-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

Intermediate for Tedizolid. Tedizolid (formerly torezolid, trade name Sivextro) is an oxazolidinone-class antibiotic for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin-structure infections (cSSSIs)). Tedizolid has been approved by the U.S Food and Drug Administration on June 20, 2014.

Specifications

Product Name:                  (R)-3-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxyMethyl)oxazolidin-2-one

Synonyms:                         N/A

CAS Number:                     504438-22-6

Molecular Weight:            337.154

Molecular Formula:          C16H21BFNO5

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OC[C@@H]1OC(=O)N(C1)c1ccc(c(c1)F)B1OC(C(O1)(C)C)(C)C

  • $1,000.00
  • Ex Tax: $1,000.00

Available Options